Mohamed Thaha

Mr. Mohamed Thaha


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in The Lancet Oncology
Verified
Journal Article
Closed access
CBCatherine Lc Bryant
Catherine Lc Bryant
PLPeter J Lunniss
Peter J Lunniss
CKCharles H Knowles
Charles H Knowles
MTMohamed Thaha
Mohamed Thaha
CCChristopher Lh Chan
Christopher Lh Chan

3 January 2013 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
NSNeel Sengupta
Neel Sengupta
CYChristopher Yau
Christopher Yau
ASAnuratha Sakthianandeswaren
Anuratha Sakthianandeswaren
DMDmitri Mouradov
Dmitri Mouradov
PGPeter Gibbs
Peter Gibbs
CLCecilia Lai
Cecilia Lai
Background: Prevalence of colorectal cancer (CRC) in the British Bangladeshi population (BAN) is low compared to British Caucasians (CAU). Genetic background may influence mutations and disease features. Methods: We characterized the clinicopathological features of BAN CRCs and interrogated their genomes using mutation profiling and high-density single nucleotide polymorphism (SNP) arrays and compared findings to CAU CRCs. Results: Age of onset of BAN CRC was significantly lower than for CAU patients (p=3.0 x 10-5) and this difference was not due to Lynch syndrome or the polyposis syndromes. KRAS mutations in BAN microsatellite stable (MSS) CRCs were comparatively rare (5.4%) compared to CAU MSS CRCs (25%; p=0.04), which correlates with the high percentage of mucinous histotype observed (31%) in the BAN samples. No BRAF mutations was seen in our BAN MSS CRCs (CAU CRCs, 12%; p=0.08). Array data revealed similar patterns of gains (chromosome 7 and 8q), losses (8p, 17p and 18q) and LOH (4q, 17p and 18q) in BAN and CAU CRCs. A small deletion on chromosome 16p13.2 involving the alternative splicing factor RBFOX1 only was found in significantly more BAN (50%) than CAU CRCs (15%) cases (p=0.04). Focal deletions targeting the 5’ end of the gene were also identified. Novel RBFOX1 mutations were found in CRC cell lines and tumours; mRNA and protein expression was reduced in tumours. Conclusions: KRAS mutations were rare in BAN MSS CRC and a mucinous histotype common. Loss of RBFOX1 may explain the anomalous splicing activity associated with CRC.

4 September 2013 in British Journal of Surgery
Verified
Journal Article
Open access
PDF file
NTN. N. Thin
N. N. Thin
EHE. J. Horrocks
E. J. Horrocks
AHA. Hotouras
A. Hotouras
SPS. Palit
S. Palit
MTMohamed Thaha
Mohamed Thaha
CKC. H. Knowles
C. H. Knowles
Background: Over the past 18 years neuromodulation therapies have gained support as treatments for faecal incontinence (FI); sacral nerve stimulation (SNS) is the most established of these. A systematic review was performed of current evidence regarding the clinical effectiveness of neuromodulation treatments for FI. Methods: The review adhered to the PRISMA framework. A comprehensive search of the literature included PubMed, MEDLINE, Embase and Evidence-Based Medicine Reviews. Methodological quality assessment and data extraction were completed in a systematic fashion. Results: For SNS, 321 citations were identified initially, of which 61 studies were eligible for inclusion. Of studies on other neuromodulation techniques, 11 were eligible for review: seven on percutaneous tibial nerve stimulation (PTNS) and four on transcutaneous tibial nerve stimulation (TTNS). On intention-to-treat, the median (range) success rates for SNS were 63 (33–66), 58 (52–81) and 54 (50–58) per cent in the short, medium and long terms respectively. The success rate for PTNS was 59 per cent at the longest reported follow-up of 12 months. SNS, PTNS and TTNS techniques also resulted in improvements in Cleveland Clinic Incontinence Score and quality-of-life measures. Despite significant use of neuromodulation in treatment of FI, there is still no consensus on outcome reporting in terms of measures used, aetiologies assessed, length of follow-up or assessment standards. Conclusion: Emerging data for SNS suggest maintenance of its initial therapeutic effect into the long term. The clinical effectiveness of PTNS is comparable to that of SNS at 12 months, although there is no evidence to support its continued effectiveness after this period. PTNS may be a useful treatment before SNS. The clinical effectiveness of TTNS is still uncertain owing to the paucity of available evidence. A consensus to standardize the use of outcome measures is recommended in order that further reports can be compared meaningfully.

28 November 2017 in BMJ Open
Verified
Journal Article
Open access
PDF file
MDMorvwen Duncan
Morvwen Duncan
EMElisavet Moschopoulou
Elisavet Moschopoulou
EHEldrid Herrington
Eldrid Herrington
JDJennifer Deane
Jennifer Deane
RRRebecca Roylance
Rebecca Roylance
KBKamaldeep Bhui
Kamaldeep Bhui
Objectives Over two million people in the UK are living with and beyond cancer. A third report diminished quality of life. Design A review of published systematic reviews to identify effective non-pharmacological interventions to improve the quality of life of cancer survivors. Data sources Databases searched until May 2017 included PubMed, Cochrane Central, EMBASE, MEDLINE, Web of Science, the Cumulative Index to Nursing and Allied Health Literature, and PsycINFO. Study selection Published systematic reviews of randomised trials of non-pharmacological interventions for people living with and beyond cancer were included; included reviews targeted patients aged over 18. All participants had already received a cancer diagnosis. Interventions located in any healthcare setting, home or online were included. Reviews of alternative therapies or those non-English reports were excluded. Two researchers independently assessed titles, abstracts and the full text of papers, and independently extracted the data. Outcomes The primary outcome of interest was any measure of global (overall) quality of life. Analytical methods Quality assessment assessing methdological quality of systematic reviews (AMSTAR) and narrative synthesis, evaluating effectiveness of non-pharmacological interventions and their components. Results Of 14 430 unique titles, 21 were included in the review of reviews. There was little overlap in the primary papers across these reviews. Thirteen reviews covered mixed tumour groups, seven focused on breast cancer and one focused on prostate cancer. Face-to-face interventions were often combined with online, telephone and paper-based reading materials. Interventions included physical, psychological or behavioural, multidimensional rehabilitation and online approaches. Yoga specifically, physical exercise more generally, cognitive behavioural therapy (CBT) and mindfulness-based stress reduction (MBSR) programmes showed benefit in terms of quality of life. Conclusions Exercise-based interventions were effective in the short (less than 3–8 months) and long term. CBT and MBSR also showed benefits, especially in the short term. The evidence for multidisciplinary, online and educational interventions was equivocal.

1 February 2013 in Colorectal Disease
Verified
Journal Article
Closed access
PDF file
AHA. Hotouras
A. Hotouras
JMJ. Murphy
J. Murphy
MTMohamed Thaha
Mohamed Thaha
CCC. L. Chan
C. L. Chan

24 August 2015 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
MTMohamed Thaha
Mohamed Thaha
AAAmin A Abukar
Amin A Abukar
NTNoel N Thin
Noel N Thin
ARAnthony Ramsanahie
Anthony Ramsanahie
CKCharles H Knowles
Charles H Knowles